BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6820200)

  • 1. Promutagen activation in partially hepatectomized mice.
    Vandewaa EA; Barney CC; Gentile JM
    Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM; DeRuiter E
    Toxicol Lett; 1981; 8(4-5):273-82. PubMed ID: 6791314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of tetramic mycotoxin cyclopiazonic acid.
    Sorenson WG; Tucker JD; Simpson JP
    Appl Environ Microbiol; 1984 Jun; 47(6):1355-7. PubMed ID: 6430233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
    Shimada T; Nakamura S; Imaoka S; Funae Y
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct mutagenicity of aflatoxin B1 and metabolites to Salmonella typhimurium: structure mutagenicity relationships and mechanisms of action.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):55-76. PubMed ID: 3118438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamins A, C, and E on aflatoxin B1-induced mutagenesis in Salmonella typhimurium TA-98 and TA-100.
    Raina V; Gurtoo HL
    Teratog Carcinog Mutagen; 1985; 5(1):29-40. PubMed ID: 2859659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
    Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
    Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding and mutagenicity of aflatoxin B1 catalyzed by isolated rabbit lung cells.
    Daniels JM; Matula TI; Massey TE
    Carcinogenesis; 1993 Jul; 14(7):1429-34. PubMed ID: 8330361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of liver S-9 preparations from rats and rainbow trout on the activity of four mutagens.
    de Flora S; Zanacchi P; Bennicelli C; Arillo A
    Toxicol Lett; 1982 Mar; 10(4):345-9. PubMed ID: 7046140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-aflatoxin mutagenic factors in corn.
    Weng CY; Martinez AJ; Park DL
    Food Addit Contam; 1997 Apr; 14(3):269-79. PubMed ID: 9135724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of water-soluble glucuronide and sulphate conjugates of aflatoxin B1. 2. Studies in primary cultures of rat hepatocytes.
    Wei CI; Hsieh DP
    Food Chem Toxicol; 1985 Sep; 23(9):821-5. PubMed ID: 3930356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
    Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
    J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of hepatic microsome-mediated bacterial mutagenesis by the rat liver soluble protein fraction.
    Saccone GT; Pariza MW
    Mutat Res; 1981 Feb; 88(2):135-45. PubMed ID: 7012606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.